Filing Details

Accession Number:
0001209191-23-021573
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-30 09:11:05
Reporting Period:
2023-03-29
Accepted Time:
2023-03-30 09:11:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1287098 Maxcyte Inc. MXCT Biological Products, (No Disgnostic Substances) (2836) MA
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1021015 Richard Douglas C/O Maxcyte, Inc.
9713 Key West Avenue, Suite 400
Rockville MD 20850
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-29 80,000 $4.32 100,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The Reporting Person purchased the securities on the open market at purchase prices ranging from $4.20 to $4.35 per share, with a weighted average purchase price of $4.3185 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.